Clinical Trial Update: Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing intramyometrial tranexamic acid to oxytocin to reduce blood loss during cesarean section; status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Intramyometrial tranexamic acid (tranexamic acid)
• Oxytocin (Oxytocin)

Snippet

Sponsor: Cairo University | Conditions: Cesarean Section Complications, Tranexamic Acid | Phase 3 | Status: NOT_YET_RECRUITING